Literature DB >> 34860474

Modifying effects of TNF-α, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study.

Liliia Fishchuk1, Zoia Rossokha1, Valeriy Pokhylko2, Yuliia Cherniavska2, Svitlana Tsvirenko2, Serhii Kovtun3, Nataliia Medvedieva1, Viktoriia Vershyhora1, Nataliia Gorovenko4.   

Abstract

OBJECTIVES: COVID-19 continues to range around the world and set morbidity and mortality antirecords. Determining the role of genetic factors in the development of COVID-19 may contribute to the understanding of the pathogenetic mechanisms that lead to the development of complications and fatalities in this disease. The aim of our study was to analyze the effect of TNF-α (rs1800629), IL-6 (rs1800795) and VDR (rs731236 and rs1544410) genes variants on the development risk and the course of COVID-19 in intensive care patients.
METHODS: The study group included 31 patients with diagnosis "viral COVID-19 pneumonia". All patients underwent standard daily repeated clinical, instrumental and laboratory examinations. Determination of IL-6, TNF-α, and VDR genes variants was performed using the PCR-RFLP method.
RESULTS: It was found a significant increase in the rate of the CC genotype and C allele (38.7 vs. 12.0% and 0.6 vs. 0.4%, respectively) of the IL-6 gene in all patients of the study in comparison with population frequencies. There was a significantly higher rate of heterozygous genotypes TC and GA of the VDR gene in group of died patients. The rs1800629 variant of the TNF-α gene is associated with the need for respiratory support and its longer duration in patients with COVID-19.
CONCLUSIONS: The obtained results support a hypothesis about the influence of variants of IL-6, TNF-α and VDR genes on severity of COVID-19. However, in order to draw definite conclusions, further multifaceted research in this area are need.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Entities:  

Keywords:  zzm321990IL-6zzm321990; zzm321990TNF-αzzm321990; zzm321990VDRzzm321990; COVID-19; gene

Mesh:

Substances:

Year:  2021        PMID: 34860474     DOI: 10.1515/dmpt-2021-0127

Source DB:  PubMed          Journal:  Drug Metab Pers Ther        ISSN: 2363-8915


  4 in total

Review 1.  Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm.

Authors:  Abdullahi Rabiu Abubakar; Rahnuma Ahmad; Adekunle Babajide Rowaiye; Sayeeda Rahman; Katia Iskandar; Siddhartha Dutta; Angus Nnamdi Oli; Sameer Dhingra; Maryam Abba Tor; Ayukafangha Etando; Santosh Kumar; Mohammed Irfan; Marshall Gowere; Kona Chowdhury; Farhana Akter; Dilshad Jahan; Natalie Schellack; Mainul Haque
Journal:  Life (Basel)       Date:  2022-03-25

2.  IFITM3, FURIN, ACE1, and TNF-α Genetic Association With COVID-19 Outcomes: Systematic Review and Meta-Analysis.

Authors:  João Locke Ferreira de Araújo; Diego Menezes; Renato Santana de Aguiar; Renan Pedra de Souza
Journal:  Front Genet       Date:  2022-04-01       Impact factor: 4.599

3.  Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population.

Authors:  Sara Falahi; Mohammad Hossein Zamanian; Parisa Feizollahi; Alireza Rezaiemanesh; Farhad Salari; Zahra Mahmoudi; Ali Gorgin Karaji
Journal:  Cytokine       Date:  2022-04-19       Impact factor: 3.926

Review 4.  Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity.

Authors:  Kajal Gupta; Gaganpreet Kaur; Tejal Pathak; Indranil Banerjee
Journal:  Gene       Date:  2022-08-17       Impact factor: 3.913

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.